Stay updated on Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial

Sign up to get notified when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change rather than any change to the study details.
    Difference
    0.0%
    Check dated 2026-04-25T17:33:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T13:08:16.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T19:47:49.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T15:49:28.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page displays a new revision label (v3.4.2) and removal of the previous label (v3.4.0). There are no changes to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-02-12T20:35:26.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:00:11.000Z thumbnail image

Stay in the know with updates to Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.